Abstract
This article presents a comprehensive review of all known elements involved in blood pressure control. Data source was by computerized literature searches. A total of 28 elements have been documented as being involved in blood pressure control. The individual elements react directly and indirectly in a variety of metabolic and structural activities known to participate in blood pressure regulation. Reports from both experimental animal and human subjects are presented. The role of certain elements in blood pressure control is controversial. Conversely, important established functions of dosage, absorption, storage, and excretion of individual elements are known and are described in relation to blood pressure control. Some elements are pressor, whereas others are depressor in action, and this article demonstrates the important role elements play in the control of blood pressure.
Similar content being viewed by others
References
B. C. Wexler,Lab. Invest. 25, 60 (1971).
V. A. Granadillo, J. E. Tahan, O. Salgado, L. E. Elejalde, B. Rodriguez-Iturbe, G. B. Romero, and R. A. Romero,Clica. Chimca. Acta. 233 (12), 47–59 (1995).
C. J. Chen, Y. M. Hsueh, M.S. Lai, M. P. Shyu, S. Y. Chen, M. M. Wu, T. L. Kuo, and T. Y. Tai,Hypertension 25 (1), 53–60 (1995).
B. Upshaw, Jr. and T. Clayborn, Jr.Sothern Med. J. 88, 892 (1995).
D. F. Bohr,Fed. Proc. 33, 127–132 (1974).
H. M. Perry, Jr., S. J. Kopp, E. F. Perry, M. W. Erlanger,J. Toxicol. Environ. Health 28, 373 (1989).
G. R. Brenniman, W. H. Kojola, P. S. Levy, B. W. Carnow and T. Nametaka,Arch. Environ. Health 36, 28 (1981).
H. A. Schroeder and W. H. Vinton, Jr.,Am. J. Physiol. 202, 515–518.
H. Perry, Jr.,Ann. NY Acad. Sci. 30, 220–221, (1978).
L. Friberg, C. G. Elinder, T. Kjellstrom, and G. F. Nordberg,Cadmium & Health, CRC Press, Chicago IL, p. 11 (1985).
H. Perry, Jr., R. Masironi, and P. Miller, J.,Trace Element Exp. Med. 4, 109–128 (1991).
H. Perry, Jr., E. Perry, and M. Erlanger, Trace Subst. in Environ. Health8, 51–57 (1974).
K. Nomiyama, H. Nomiyama, S. Lui, Y. Ishimaru and M. Hirai,Ann. NY Acad. Sci. 676, 308–326 (1993).
H. M. Perry and S. I. Kopp,Sci. Total Environ. 26, 223–232 (1983).
D. M. Medeiros and L. K. Pellum,Bull. Environ. Contam. Toxicol. 32, 525–532 (1984).
H. A. Schroder, A. P. Nason and I. H. Tipton,J. Chronic Dis. 20, 769–790 (1967).
V. Karlicek, D. Topolcan, T. Bilbova, J. Kott, J. Sova,Cas. Lek. Ces. 110, 32 (1971).
T. L. M. Syverson, T. K. Sbrong, G. B. Syverson, and J. Opstad,Scand. J. Lab. Invest. 36, 251–256 (1976).
S. Inderaprasit, G. V. Alexander, H. C. Gonick,J. Chronic Dis. 27, 135 (1974).
K. Ostergard,Lancet 1, 677–678 (1977).
D. Beevers, B. Campbell, A. Goldberg, M. Moore, and V. Hawthorne,J. Lancet 2, 1222–1225 (1976).
P. Wester,Acta. Med. Scand. 194, 505–512 (1973).
N. W. Revis and A. R. Zinsmeister,Proc. Soc. Exp. Biol. Med. 167, 254–260 (1981).
H. A. Schroeder and H. M. Perry,J. Lab. Clin. Med. 46, 416–422 (1955).
P. Weldman, S. G. Massry, J. W. Coburn, et al.,Ann. Intern. Med. 76, 741–745 (1972).
D. A. McCarron, C. D. Morris, H. J. Henry, et al.,Science 224, 392 (1984).
F. P. Cappuccio, A. Siani, and P. Strazzullo,J. Hypertens 7, 941–946 (1989).
J. M. Earll, N. A. Klurtman, and R. H. Moser,Ann. Int. Med. 64, 378–381 (1966).
L. Lind, A. Hanni, A. Hvarfner, T. Pollare, S. Ljunghall, H. Lithell,Am. J. Hypertens.,7, 302–7 (1994).
H. Tamura,J. Jpn. Nephrol. 29, 107–113 (1987).
H. Zhou, S. Fan, L. Zhou, Y. Ni, T. Huang, and Y. Shi,Am. J. Hypertens. 7, 363–7 (1994).
L. M. Resnick,Cardiovasc. Rev. and Rep. 9, 1341–1350 (1982).
H. Bucher, G. Guyatta, R. Cook, R. Hatala, D. Cook, et al.,JAMA 275, 1113–1117 (1996).
L. Goodman and A. Gillmans, Water, salts, and ions, InThe Pharmacological Basis of Therapeutics, MacMillan, p. 600 (1943).
D. F. Bohr,Science 139, 597 (1963).
E. W. Young, R. D. Bukowski, and D. A. McCarron,Proc. Soc. Exp. Biol. Med. 187, 123 (1988).
A. Ayach,Metabolism 28, 1234–1238 (1979).
D. McCarron, N. N. Yung, B. A. Ugoretz, and S. Krutzik,Hypertension 2, 162–167 (1981).
H. A. Schroeder,J. Chronic Dis. 14, 236 (1961).
H. A. Schroeder, A. P. Nason, and I. H. Tipton,J. Chronic Dis. 20, 769–790 (1967).
D. Cushman and H. Cheung,Biochem. Biophys. Acta. 250, 261–265 (1971).
Y. Morin and P. Daniel,J. Can. Med. Assoc. 97, 926–931 (1967).
V. Morvai, E. Szakmary, E. Tatrai, G. Ungvary, and G. Folly,Acta. Physiologica. Hungarica 81 (3), 253–61 (1993).
M. Fields, R. Ferretti, J. Smith, and S. Reiser,Am. J. Clin. Nutr. 39, 289–295 (1984).
Y. S. Bakhle and A. M. Reynard,Nature New Biol. 229, 187–189 (1971).
F. E. Dorer, L. T. Skeggs, J. R. Khan, et al.,Anal. Biochem. 33, 102–113 (1970).
H. P. Schedl, M. L. Failla, and H. D. Wilson,Nutr. Res. 6, 1201–1209 (1986).
H. F. Loyke,Biol. Trace Element Res. 29, 45–49 (1991).
M. J. Fregly, J. F. Gennaro, and A. B. Otis,Circ. Res 8, 749–758 (1960).
M. J. Fregly,Am. J. Physiol. 194, 149 (1958).
M. J. Fregly and C. L. Hood,Circ. Res. 7, 486 (1959).
H. A. Schroeder,Circulation 35, 570–582 (1967).
H. F. Loyke,Biol. Trace Element Res. 25, 47–50 (1990).
P. Samuels, E. K. Main, M. T. Mennuti, and S. G. Gabbe,Am. J. Obstet. Gynecol. 157, 721–725 (1987).
S. Entman, L. Richardson and A. Killam,Am. J. Obstet. Gynecol. 143, 398–404 (1982).
L. Goodman and A. Gillman, ed. R. S. Hilmam, C. A. Finch, Drugs Effective in Iron-Deficiency,The Pharmacological Basis of Therapeutics, MacMillan, p. 1310 (1985).
W. Victery, A. Vander, J. Schoeps, and S. Julius,J. Lab. Clin. Med.,99, 354 (1982).
H. F. Loyke,Bull. Environ. Contam. Toxicol. 34, (5), 730–735 (1985).
L. Neri and H. Johansen,Ann. NY Acad. Sci. 15, 203–221 (1978).
J. L. Pirkle, J. Schwartz, J. R. Landis, and W. R. Harlan,Am. J. Epidemiol.,121, 246–258 (1985).
V. Batuman, E. Landy, J. K. Maesaka, and R. P. Wedeen,N. Engl. J. Med.,309, 17–21 (1973).
I. Bach, S. Braun, T. Gati, et al.,Nature 192, 362–363 (1961).
H. E. Hansen and A. Amdisen,Q. J. Med. 47, 123–144 (1978).
A. Kierkegaard-Haren,Acta. Pharmacol. Toxicol. 35, 370–378 (1974).
J. Michael, D. Ben-Ishay, et al.,JAMA 251, 1690 (1984).
P. K. Zacharish and A. H. Rosenbaum,Mayo Clin. Proc. 57, 625–628 (1982).
B. M. Altura, B. T. Altura, A. Gebrewald, et al.,Science 223, 1315–1317 (1984).
A. K. Sangal and D. G. Beevers,Lancet 2, 498, (1982).
M. L. McCall and D. Sass,Am. J. Obstet. Gynecol. 71, 1089 (1956).
L. M. Resnick, J. P. Nicholson, and J. H. Laragh,J. Cardiovasc. Pharmacol. 6, (1985).
T. Fujita, Y. Ito, H. Noda, and E. Ogata,Circulation 82, 384–393 (1990)
C. P. Campanile, J. K. Crane, M. J. Peach, and J. C. Garrison,J. Biol. Chem. 257, 4951–4958 (1982).
R. N. Stevenson, C. Keywood, A. Amadi, J. Davies, and D. Patterson,Heart 5,66, 19–21 (1991).
F. Corica, R. Ientile, A. Allegra, G. Romano, et al.,Biol. Trace Element Res.,51, 13–21 (1996).
J. C. Boyd and D. E. Burns,Clin. Chem. 29, 178 (1983).
H. A. Schroeder,J. Chronic Dis. 18, 217–228 (1965).
H. M. Perry, Jr. and H. A. Schroder,J. Lab. Clin. Med. 46, 936 (1955).
L. S. Goodman, A. G. Gillman, and S. C. Harvey eds., Heavy metals, inThe Pharmacological Basis of Therapeutics, MacMillan, NY, p. 937 (1975).
A. M. Cirla, S. Costantini, A. B. Lemoxta,Med. Lavoro 61, 569–579 (1970).
C. G. Huggins, R. J. Corcoran, J. S. Gordon, et al.,Circ. Res. (Suppl. I),27, (1970).
W. R. Harlan, A. L. Hill, R. P. Schmouder, et al., Dietary Intake & Cardiovascular Risk Factors, DHHS publication no. (PHS), Hyattsville, MD, p. 1676 (1983).
H. G. Langford, J. C. Nainby-Luxemore, N. C. Nelson, et al.,Clin. Res. 28, 333A (1980).
E. I. Bloomguist, A. W. I. El-Bermarir, E. C. Yancey, and V. Karr-Dullion,Clin. Exp. Hyperten., (5), 447–453 (1983).
R. J. M. Bindels, L. A. M. van den Broek, S. J. W. Hillebrand, and J. M. P. Wokke,Hypertension 9, 96–102 (1987).
L. Tobian, J. Lange, K. Ulm, et al.,Hypertension (Suppl. I)7, (1985).
G. Krishna,J. Am. Soc. Nephrol. 1, 43–52 (1990).
H. E. Jang, S. T. Grethe, T. Yuan-Chang, et al.,Hypertension 17, (3), 378–395 (1991).
R. L. Watson, H. G. Langford, J. D. Abernethy, et al.,Hypertension 2, (42), 93–98 (1980).
G. Bunge,Textbook of Physiological & Pathological Chemistry, McGraw-Hill, NY, p. 73 (1902).
D. Santoro, A. Natali, C. Polumbo, et al.,Hypertension 28, 181–191 (1992).
Y. Gelinas and J. P. Schmit,Biometals 7, 155–162 (1994).
V. E. Lavine,Ann. NY Acad. Sci. 26, 385–394 (1915).
F. Czapek and J. Weil,Arch. Exp. Pathol. Pharmacol. 32, 438–455 (1893).
H. Perry, Jr., E. Perry, and M. Erlanger,Trace Substances in Environmental Health, D. D. Hemphill, ed., University of Missouri, Columbia, MO, p. 51 (1974).
H. D. Anderson and A. L. Moxon,J. Pharmacol. Exp. Ther. 76, 343–354 (1942).
C. O. Jones,Biochem. J. 4, 403–419 (1909).
M. A. Heinrich, Jr. and D. M. MacCanon,Toxicol. Appl. Pharmacol. 2, 33–43 (1960).
H. Hilse, P. Ochme, W. Krause and K. Aecht,Acta. Physiol. Pharmacol. Biol. 5, 47–50 (1979).
H. F. Loyke,Biol. Trace Element Res. 33, 129–133 (1992).
T. A. Miettinen, G. Alfthan, J. K. Huttunen, et al.,Br. Med. J. 287, 517–519 (1983).
M. F. Robinson and C. S. Thomson,Nutrition Abstracts and Reviews—A 53, 3–26 (1983).
Y. Deguchi,Jpn. J. Hyg. 39, 924–929 (1985).
J. Tuomilehto,Prev. Med. 14, 413–427 (1985).
L. Ambard and E. Beaugard,Classics in Arterial Hypertension, Charles C. Thomas, Springfield, IL, p. 297 (1956).
L. A. Saperstein, W. L. Brandt, and D. R. Drury,Proc. Soc. Exp. Biol. Med. 73, 82–85 (1950).
G. Rose and J. Stamler,J. Hum. Hypertens..3, 283–288 (1989).
G. MacGregor, E. Mervaala, H. Kappanen, et al.,Lancet 343, 545–546 (1994).
I. H. Page,Hypertension Mechanisms, Bruce Stratton, Orlando FL, p. 211 (1987).
M. Maxwell, A. U. Waks, and P. Orlando,Clinical Disorders of Fluids and Electrolyte Metabolism. W. B. Sanders, Philadelphia, PA, p. 869 (1987).
T. Kawasaki, C. S. Dlea, F. C. Bartter, et al.,Am. J. Med. 64, 193–198 (1978).
T. M. Morgan, R. Creed, and J. Hopper,Clin. Exp. Hypertens. Theory Prac. A8, 941–962 (1986).
L. M. Resnick, J. H. Laragh, J. E. Sealey, et al.,N. Engl. J. Med. 309, 888–891 (1983).
V. M. Campese, M. S. Romoff, D. Levitan, et al.,Kidney Int. 21, 371–378 (1982).
M. I. Koolen and P. V. VanBrummelen,Hypertension 6, 825–860 (1984).
J. P. Midgley, A. G. Matthew, C. M. Greenwood, and A. G. Logan,JAMA,275, 1590–1597 (1996).
W. J. Bank, D. E. Pleasure, K. Suzuki, M. Nigro, and R. Katz,Arch. Neurol. 26, 456–464 (1972).
B. Escalante, D. Sacerdoti, M. M. Davidian, et al.,Hypertension 17, 776–779 (1991).
J. Balassa and I. Tipton,J. Chronic Dis. 17, 483 (1964).
M. Laniado Schwartzman, N. B. Abraham, D. Sacerdoti, B. Escalante, J. C. McGiff, and J. Tohoku,J. Exp. Med.,166 (1), 85–91 (1992).
J. L. DaSalva, M. Tiefenthaler, E. Park, B. Escalante, M. L. Schwartzman, R. D. Levere, and N. G. Abraham,Am. J. Med. Sci. 307, (3), 173–181 (1994).
P. Boscolo, M. Carmignani, A. R. Volpe, M. Felaco, G. DelRosso, G. Porcelli and G. Giuliano,Occup. Environ. Med. 51 (7), 500–3 (1994).
C. L. White, I. Jacob, H. Dahlenim, J. Pachorr, C. F. Mills, I. Bremner, J. K. Chester, eds. Fifth International Symposium on Trace Elements in Man and Animals, Farnham Royal Commonwealth Agricultural Bureau, p. 65 (1985).
J. C. Schwartz, G. Gros, J. M. Lecomte, and J. Bralet,Life Sci. 47, 1279–1297 (1990).
G. Vivoli, M. Bergomi, R. Sergio, et al.,Zinc. Copper, and Zinc- or Copper-Dependent Enzymes in Hum. Hypertens. 49, 97–107 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Loyke, H.F. Effects of elements on blood pressure. Biol Trace Elem Res 58, 1–12 (1997). https://doi.org/10.1007/BF02910661
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02910661